VEEV

$184.07-1.52 (-0.82%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Veeva Systems Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$184.07
Potential Downside
39.1%
Whystock Fair Value$112.17
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pha...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$30.26B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
33.77
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.12
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
12.91%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
7.53

Recent News

Insider Monkey
Mar 20, 2026

Veeva Systems (VEEV) Reiterated Confidence in Achieving Its 2030 Financial Targets

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -3.55% (gross) and -3.76% (net) in the fourth quarter compared to a -3.70% return for the Russell Midcap Growth Index. In 2025, the strategy returned 14.84% […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 20, 2026

A Look At Veeva Systems (VEEV) Valuation After New AOP Health Cloud Adoption Win

Veeva Systems (VEEV) is back in focus after AOP Health chose its Development, Quality, Commercial, and Data Clouds to run integrated rare disease and intensive care programs, connecting research with commercialization. See our latest analysis for Veeva Systems. The AOP Health win comes at a time when Veeva’s recent 7 day share price return of 2.66% and 30 day share price return of 4.96% contrast with a 1 year total shareholder return decline of 21.31%. This suggests that short term momentum...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 17, 2026

Is Veeva Systems (VEEV) A Good Stock To Buy Now?

Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on LongTermValue Research’s Substack. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc.’s share was trading at $185.28 as of March 16th. VEEV’s trailing and forward P/E were 34.06 and 20.92 respectively according to Yahoo Finance. […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

Veeva Systems (VEEV) Just Overtook the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 16, 2026

How Much Upside is Left in Veeva (VEEV)? Wall Street Analysts Think 52.1%

The average of price targets set by Wall Street analysts indicates a potential upside of 52.1% in Veeva (VEEV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.